Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.

Triumphs of COVID-19 included rapid vaccine development and scientific collaboration. But the tragedies were numerous.